Healthcare company-building profile
Cincinnati Children's Innovation Ventures
Cincinnati Children's
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Health system accelerator
- Organization
- Cincinnati Children's
- Organization type
- Hospital or health system
- Location
- Cincinnati, Ohio
- Company stage served
- Research or idea stage
- Cohort or participation model
- Not publicly documented
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Yes
- Application status
- Active
Public description
About the program
Innovation Ventures is Cincinnati Children's named program for translating pediatric research and clinical ideas into products, services, and companies. It handles invention disclosure, patent prosecution, and licensing across diagnostics, therapeutics, medical devices, research tools, software, and educational and consumer products, and maintains a searchable public database of technologies available for license. The team also structures collaborative and sponsored research agreements, identifies solutions for high-value unmet clinical needs, and forms startups around institutional intellectual property. Outside companies engage through licensing, spinout co-founding, strategic partnerships, and piloting or co-developing products with the hospital's clinical and research faculty.
What the program publicly emphasizes
Focus areas and features
- Category: Health system accelerator
Publicly documented people and network
Program leadership and alumni
- Program leader
- Nicholas Archer — Vice President of Innovation Ventures
- Notable alumni named in public materials
- 1,000+ active invention disclosures; 2,500+ unique inventors; 350+ projects advanced for commercial potential; 300+ active innovations across the life sciences; supported by $305 million in annual external research funding including more than $200 million from the NIH; commercialization routes include license, spinout, and strategic partnership; no named spinouts, licensing revenue totals, or exit figures are published on the program's pages
Sources
External source links open in a new tab.